Recruiting

SoLá Pelvic Therapy

Sponsor:

SoLa Pelvic Therapy

Code:

NCT07799857

Conditions

Chronic Pelvic Pain

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SoLá Pelvic Therapy (SPT)

Study Details

Brief summary:

The VOICE Registry is a multicenter, prospective, observational registry designed to collect real-world data on the clinical use of SoLá Pelvic Therapy® (SPT) in patients with chronic pelvic pain (CPP). The registry will follow patients receiving transvaginal photobiomodulation (PBM) therapy with SPT as part of their standard clinical care. The primary purpose of the registry is to collect real-world evidence on the use and safety of SPT.

Conditions

Chronic Pelvic Pain

Study ID

NCT07799857

Start date

Apr 6, 2026

Status verified date

Aug, 2026

Completion date

Apr, 2030

Anticipated

Primary completion date

Apr, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 18 years or older.
  • Selected to receive transvaginal photobiomodulation therapy with the SoLá Pelvic Therapy® as part of their standard clinical care.

Exclusion Criteria:

\- Patients will be excluded from the registry only if the treating healthcare professional determines that SoLá Pelvic Therapy® is not appropriate or contraindicated.

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Arms

Patients Receiving SoLá Pelvic Therapy

Patients with chronic pelvic pain receiving SoLá Pelvic Therapy (SPT) as part of routine clinical care. Participants are followed prospectively through the registry to collect treatment, use and safety information.

Interventions

SoLá Pelvic Therapy (SPT)

SoLá Pelvic Therapy (SPT) is administered as part of routine clinical care to patients with chronic pelvic pain. Treatment is not assigned by the registry. The registry prospectively collects treatment, and safety information from patients receiving SPT at participating sites.

Primary outcome measure

  • Change in Chronic Pelvic Pain Severity [ Time Frame: Baseline through 12 months ]

Central Contacts and Locations

Central contacts

Georgine Lamvu, MD, MPH

407-461-1189georgine@solapelvictherapy.com

Pilar Garcia, MD

561-850-1629pilar@solapelvictherapy.com

Locations

Zipper Urogynecology Associates

Recruiting

Melbourne, Florida, United States, 32901

More Information

Sponsor

SoLa Pelvic Therapy

Last update posted

Sep 2, 2026

Last verified

Aug, 2026

Keywords

  • Chronic Pelvic Pain
  • Pelvic Pain
  • Photobiomodulation
  • Transvaginal Photobiomodulation
  • SoLá Pelvic Therapy
  • Pelvic Floor Dysfunction

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by SoLa Pelvic Therapy on 2026-09-02.